| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | buprenorphine (Butec®) |
| Formulation | 5 micrograms/hour, 10 micrograms/hour and 20 micrograms/hour transdermal patch |
| Reference number | 2930 |
| Indication | Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Butec is not suitable for the treatment of acute pain |
| Company | Qdem Pharmaceuticals Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 03/11/2015 |